Of all the concerns men bring through the clinic door, premature ejaculation may be the one most surrounded by silence. Most men with it think they are alone in having it. They are not — community-based surveys put the prevalence somewhere between 20% and 30%, making it the most common male sexual dysfunction across age groups.1 The literature is much larger than the cultural conversation suggests.
It is also, helpfully, one of the most treatable conditions in our specialty. The catch is that "treatment" only works when it is matched to the underlying pattern — and clinics that hand every patient the same prescription tend to disappoint a lot of patients.
What we are actually treating
The International Society for Sexual Medicine's evidence-based definition has three components: ejaculation that occurs within about one minute of vaginal penetration (lifelong) or a clinically meaningful reduction of latency to about three minutes or less (acquired); an inability to delay ejaculation on most or all penetrations; and personal distress as a result.2 All three matter. Without distress, there is no condition to treat — only a number.
That tidy definition obscures two distinctions that determine everything about the treatment plan:
- Lifelong vs. acquired. Lifelong PE has been the pattern since the first sexual experience; acquired PE represents a change from a previously normal baseline. The mechanisms differ. Acquired PE is more likely to ride alongside erectile dysfunction, prostatitis, thyroid disease, or relationship stress.2,3
- Generalized vs. situational. Generalized PE happens with every partner and every context. Situational PE is selectively triggered — often by novelty, infrequent sex, or specific dynamics. Situational PE responds particularly well to behavioral and psychological work; generalized lifelong PE responds best to pharmacology.
The first appointment, more than anything, is an effort to sort men into the right bucket. The rest is downstream of that.
Behavioral techniques — what they can and can't do
The two best-known techniques are stop–start (described by Semans in the 1950s) and squeeze (Masters and Johnson, 1970). Both work by interrupting stimulation just short of the point of ejaculatory inevitability, building a felt sense of where the threshold is, and gradually pushing it back.
A 2015 Cochrane review evaluated 12 randomized trials and found that behavioral techniques alone produced a meaningful improvement in intravaginal ejaculatory latency time (IELT) of roughly seven to nine minutes over no treatment, but the quality of evidence was rated low to moderate due to small samples and inconsistent reporting.4 A more recent systematic review found that the combination of behavioral techniques with pharmacotherapy outperformed pharmacotherapy alone on IELT and on patient-reported satisfaction.5
The clinical reading: behavioral therapy is genuinely useful but rarely sufficient on its own for lifelong PE, where the latency is in the seconds and the partner is unlikely to remain patient through twelve weeks of squeeze training. Where it does shine is acquired and situational PE, performance anxiety, and as a complement to medication in any case.
Pelvic floor training
The pubococcygeus and bulbospongiosus muscles play a role in the expulsion phase of ejaculation, and a 2014 randomized trial by La Pera and colleagues, plus several follow-up studies, have shown that a structured 8–12 week pelvic floor rehabilitation programme can improve IELT in lifelong PE in roughly 55–80% of men who complete it.6 The benefit appears to persist past the active training period — unusual in this field. It requires a competent physiotherapist and patient commitment, and it is underused in our region.
Behavioral and pelvic floor work are slow but underrated. For situational PE — and for any man who prefers not to be on continuous medication — they are often the first thing to try. For severe lifelong PE, they are almost always a useful add-on rather than a stand-alone answer.
Topical anesthetics
Topical lidocaine–prilocaine preparations (cream or, in more controlled doses, a metered-dose spray) reduce penile sensitivity and increase IELT. The metered-dose spray formulation studied in two phase III trials produced a roughly six-fold increase in geometric mean IELT versus placebo, with statistically significant improvements in patient-reported control and satisfaction.7
The advantages are real: rapid onset (10–15 minutes), on-demand use, no systemic effects. The disadvantages are equally real: imperfect application can numb the partner if a condom is not used, the cream can feel clinical, and a small fraction of men find the loss of sensation itself dampens pleasure. We tend to recommend topicals as a starting point for men who do not want a daily medication or who have only occasional symptoms — and as a low-effort first move while a more durable plan is being built.
Off-label SSRIs and dapoxetine
The unintended sexual side effect of delayed ejaculation that has frustrated millions of patients on antidepressants is, in this context, the entire point.
Dapoxetine is the only SSRI specifically developed and approved for PE in many countries. It has a short half-life designed for on-demand use 1–3 hours before sex. The pooled phase III trials reported a roughly threefold improvement in IELT and significant gains in control and satisfaction.8 The most common side effects are nausea, dizziness and headache; orthostatic hypotension is uncommon but worth screening for. In the Philippines and across Asia, dapoxetine is available but not always the most affordable option.
The off-label SSRIs used daily — paroxetine 20 mg, sertraline 50–100 mg, fluoxetine 20 mg, escitalopram 10–20 mg — all increase IELT, with paroxetine producing the largest effect in network meta-analyses (roughly an 8.8-fold increase versus placebo).9 The trade-off is that daily SSRIs need 2–3 weeks to reach steady state and carry the more familiar SSRI side-effect profile: reduced libido in a subset, GI symptoms, occasional sweating, and the well-known discontinuation syndrome if stopped abruptly.
Clomipramine, an older tricyclic, also works — sometimes more powerfully than the SSRIs — but its anticholinergic side effects make it a less common first choice.
PDE5 inhibitors — when ED and PE overlap
Up to 40% of men with PE also have some degree of erectile difficulty, and the two are mechanistically intertwined: anxiety about losing an erection can hasten ejaculation, and a less reliable erection forces a man to rush.10 A 2019 meta-analysis found that PDE5 inhibitors alone produced a modest improvement in IELT, but in combination with an SSRI they consistently outperformed SSRI monotherapy on both IELT and overall satisfaction.10
The takeaway: a man with both conditions, particularly when the ED came first, is often best treated for the ED first. PE may resolve in part on its own once erection confidence is restored.
What combination protocols actually look like in practice
A common — and well-supported — sequence we use looks something like this:
- Assessment. Sort lifelong vs. acquired, generalized vs. situational; screen for ED, thyroid, prostatitis, relationship stress.
- Start with the smallest viable intervention. For situational PE in a man with no ED, that often means behavioral work plus a topical agent on demand. For severe lifelong PE, that often means dapoxetine on demand or a daily SSRI at the lowest effective dose.
- Layer when needed. If the IELT improvement is partial after 6–8 weeks, consider adding a topical to a daily SSRI, or adding pelvic floor rehab, or — in men with concurrent ED — adding a PDE5 inhibitor.
- Re-evaluate every 12 weeks. Most men can step down from daily medication to on-demand within 6–12 months, particularly if behavioral skills have been consolidated alongside the pharmacology.
| Approach | Typical IELT effect | Best suited for |
|---|---|---|
| Behavioral + pelvic floorStop–start, squeeze, PFM training | Moderate (7–9 min over baseline); slower onset | Situational PE, acquired PE, patients avoiding medication |
| Topical lidocaine–prilocaineCream or metered-dose spray | Large (~6× baseline) | Occasional symptoms, on-demand preference, no daily medication |
| Dapoxetine on demand | ~3× baseline IELT | Lifelong PE with predictable sexual frequency |
| Daily SSRI (paroxetine, sertraline, etc.) | Up to ~8.8× (paroxetine) baseline | Severe lifelong PE, men who prefer spontaneity over pre-dosing |
| PDE5 inhibitor (added) | Adjunctive — improves control further | Overlapping ED, performance anxiety |
What's overhyped
A short list of things that recur in online marketing and that we are repeatedly asked about:
- "Climax-control" condoms. Functionally a thin layer of benzocaine on the inside. They can help marginally for very mild cases. Treat them as a topical agent in cheaper packaging, not a treatment.
- Supplements marketed for PE. Most are blends of vitamins, minerals, or herbal extracts (folate, zinc, ashwagandha, Tribulus) that have no demonstrated effect on IELT in well-controlled trials. The evidence for any consistent benefit is weak.11
- "Penile injections for PE." Hyaluronic acid injections into the glans to reduce sensitivity have been promoted in some cosmetic settings; the evidence base is small, the procedure is operator-dependent, and results are not predictable. Not something we recommend.
- One-off "shockwave for PE" packages. Shockwave therapy has good evidence in vasculogenic ED. Its evidence base in PE is, at the time of writing, thin. Beware of clinics selling the same device as a universal answer.
When to see a clinician
If PE is causing personal distress, affecting a relationship, or has appeared as a new change after years of normal function, it is worth a single appointment. The first visit is mostly conversation: pattern, history, screening for the conditions that mimic or aggravate PE. The plan is almost always less aggressive than men expect — and the prognosis, for most men, is genuinely good.
The thing we hear most often, weeks into treatment, is some version of "I should have come in earlier." The condition does not improve by being ignored. It does improve, reliably, when it is named.